HuMax-TAC

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHuMax-TAC
Drug Alias Nameanti-IL-2R antibody (Genmab/Merck Serono)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-2 receptor alpha chain modulators
TargetsInterleukin-2 receptor alpha chain
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host DiseaseAutoimmune Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenmab A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaGenmab A/S
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationGraft vs Host DiseaseAutoimmune Diseases +[6] 

Other Information

ATC CodeN/A
Related LinksN/A